At Obsidian, our vision is pioneering engineered cell & gene therapies to deliver transformative outcomes for patients.
Obsidian Therapeutics is a pioneering force in biotechnology research, dedicated to engineering transformative cell and gene therapies for patients facing intractable diseases. With a focus on innovation and therapeutic efficacy, Obsidian Therapeutics is committed to delivering groundbreaking outcomes in areas of greatest clinical need.
Located at 1030 Massachusetts Avenue, Suite 400, Cambridge, MA 02138, US, Obsidian Therapeutics is driven by its cytoDriveTM technology. This innovative approach allows for precise control of protein expression in cell and gene therapy products, enhancing therapeutic impact. Obsidian Therapeutics' lead program, cytoTIL15, exemplifies this commitment by engineering TILs to be more effective for a broader range of patients.
Obsidian Therapeutics aspires to deliver transformative therapies and invites you to explore potential collaborations and opportunities. For more information and to further explore how Obsidian Therapeutics is revolutionizing the field, we encourage you to connect with us. Management is actively working to complete our showcase. We invite the manager to create a customized and exclusive company showcase and product listing on our platform.
Other organizations in the same industry
This company is also known as